Corcept Therapeutics Incorporated (CORT)

2seventy bio Market Cap

Corcept Therapeutics has a market cap or net worth of $7.58 billion as of August 11, 2025. Its market cap has increased by 111.25% in one year.

• Market Cap: 7.58B
• Enterprise Value: 7.08B
• 1-Year Change: 111.25%
• Ranking: #1035
• Category: Mid-Cap
• Stock Price: $71.97

Market Cap Chart

Since April 14, 2004, Corcept Therapeutics's market cap has increased from $283.00M to $7.58B, an increase of 2,579.72%. That is a compound annual growth rate of 16.67%.

Market Cap History

Date	Market Cap	% Change
Aug 8, 2025	7.62B	44.30%
Dec 31, 2024	5.28B	57.69%
Dec 29, 2023	3.35B	53.13%
Dec 30, 2022	2.19B	-4.35%
Dec 31, 2021	2.29B	-24.78%
Dec 31, 2020	3.04B	119.78%
Dec 31, 2019	1.38B	-10.36%
Dec 31, 2018	1.54B	-25.15%
Dec 29, 2017	2.06B	155.69%
Dec 30, 2016	806.10M	48.81%
Dec 31, 2015	541.70M	78.43%
Dec 31, 2014	303.60M	-5.24%
Dec 31, 2013	320.40M	124.53%
Dec 31, 2012	142.70M	-50.47%
Dec 30, 2011	288.10M	3.11%
Dec 31, 2010	279.40M	60.85%
Dec 31, 2009	173.70M	248.10%
Dec 31, 2008	49.90M	-59.17%
Dec 31, 2007	122.20M	336.43%
Dec 29, 2006	28.00M	-66.22%
Dec 30, 2005	82.90M	-41.54%
Dec 31, 2004	141.80M	-49.89%
Apr 14, 2004	283.00M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	561.67B
Johnson & Johnson	417.44B
AbbVie	349.87B
Abbott Laboratories	233.71B
AstraZeneca	227.85B
UnitedHealth Group	227.59B
Novartis AG	225.61B
Novo Nordisk	224.34B